Iqvia has led a $15m series C round for MIT-founded genomic data analytics spinout BC Platforms as part of a strategic partnership agreement.

BC Platforms, a Switzerland-based genomic data management and analytics spinout of Massachusetts Institute of Technology, closed a $15m series C financing round today led by medical services outsourcing company Iqvia as part of a strategic collaboration.
The round was backed by Debiopharm Innovation Fund, a strategic investment vehicle of biopharmaceutical development group Debiopharm, and was filled out by Finnish government-owned investment firm Finnish Industry Investment (Tesi).
Founded in 1997, BC Platforms provides pharmaceutical developers with genomic data management…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?